What is the recommended management for iatrogenic Cushing syndrome?

Management of Iatrogenic Cushing Syndrome

The cornerstone of managing iatrogenic Cushing syndrome is immediate discontinuation or gradual tapering of the offending exogenous glucocorticoid, followed by physiological glucocorticoid replacement with hydrocortisone 10-12 mg/m²/day in divided doses until HPA axis recovery occurs (typically 6-18 months). 1

Primary Management Strategy

Step 1: Discontinue the Causative Agent

• Identify and stop the exogenous glucocorticoid source - this includes obvious sources (oral/IV steroids) and hidden sources (topical eye drops, intra-articular injections, intranasal steroids, over-the-counter supplements with undisclosed steroids) 2, 3, 4, 5
• The taper speed depends on duration of use and HPA axis suppression severity
• Never abruptly stop long-term corticosteroids - this precipitates adrenal crisis 3

Step 2: Initiate Physiological Glucocorticoid Replacement

Hydrocortisone is the preferred agent because synthetic glucocorticoids with longer half-lives prolong HPA axis suppression 1

Dosing regimen:

• Hydrocortisone 10-12 mg/m²/day divided 2-3 times daily
• First dose immediately upon waking
• If hydrocortisone unavailable, use lowest possible replacement dose of alternative glucocorticoids 1

Critical patient education:

• Provide written stress-dosing instructions for intercurrent illness
• Supply injectable emergency steroids
• Obtain medical alert identification indicating adrenal insufficiency 1

Step 3: Monitor for Glucocorticoid Withdrawal Syndrome

Warn patients this is common and expected - they will paradoxically feel worse after stopping excess steroids 1

Withdrawal symptoms include:

• Anorexia, nausea, weight loss
• Fatigue, flu-like myalgias, arthralgias, lethargy
• Skin desquamation
• Atypical depression, anxiety, panic symptoms in adults
• Recovery may take ≥1 year, even after HPA axis recovers 1

Management approach:

• Frequent support and reassurance (most important intervention)
• Temporary glucocorticoid dose increase if severe, but reduce quickly to avoid re-inducing iatrogenic Cushing syndrome
• Consider SSRIs for mood symptoms (though not systematically studied)
• Engage family, friends, and patient support groups 1

HPA Axis Recovery Monitoring

Assessment schedule:

• Check morning cortisol (before that day's glucocorticoid dose) every 3 months 1

Interpretation algorithm:

• Cortisol ≥7.4 μg/dL (200 nmol/L): Proceed to ACTH stimulation test
• Baseline or stimulated cortisol ≥18 μg/dL (500 nmol/L): HPA axis recovered - discontinue glucocorticoids 1
• Cortisol <5 μg/dL (138 nmol/L): Continue glucocorticoids, retest in 3-6 months
• Intermediate values: Use clinical judgment and consider stimulation testing 1

Expected recovery timeline:

• Adults: 6-12 months after ACTH-producing tumor resection
• Adults: ~18 months after unilateral adrenalectomy
• Pediatrics: Mean 12.6 ± 3.3 months
• Bilateral adrenalectomy: Lifelong replacement required 1

Special Considerations and Pitfalls

Diagnostic Challenge

Biochemical paradox: Iatrogenic Cushing syndrome presents with classic Cushingoid features BUT laboratory findings show hypocortisolism and suppressed ACTH due to HPA axis suppression 2. This can mask the diagnosis - always obtain detailed medication history including supplements, topical preparations, and injections.

Hidden Steroid Sources

Be vigilant for:

• Topical ocular corticosteroids (especially in children) 3
• Intra-articular corticosteroid injections for osteoarthritis 4
• Inhaled/intranasal steroids, particularly with concurrent CYP450 inhibitors 6
• Over-the-counter supplements with undisclosed glucocorticoids 5

Concurrent Complications

Address systemic complications that increase morbidity and mortality:

• Metabolic decompensation and uncontrolled diabetes
• Increased infection susceptibility (cellulitis, opportunistic infections)
• Cardiovascular disease and atrial fibrillation
• Osteoporosis and fragility fractures
• Aseptic necrosis of femoral head
• Benign intracranial hypertension 2, 6, 5

Re-evaluate Other Pituitary Deficiencies

Hypercortisolism causes functional central hypothyroidism and hypogonadism that may resolve after 6 months, but patients may need continued replacement 1

Avoid Supraphysiological Dosing

While some practitioners use higher doses (hydrocortisone 20 mg 2-3 times daily) postoperatively, no controlled studies support this approach, and it risks continued excessive glucocorticoid exposure 1